Literature DB >> 9093340

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

E Piitulainen1, G Tornling, S Eriksson.   

Abstract

BACKGROUND: Severe alpha 1-antitrypsin (AAT) deficiency (PiZZ) is associated with an increased risk of lung emphysema, especially in smokers. The aim of this study was to identify risk factors other than smoking for declining lung function.
METHODS: Lung function was studied in 225 self-reported never-smoking PiZZ individuals included in the Swedish AAT deficiency register.
RESULTS: Lung function was poorer in men than in women (mean (SD) forced expiratory volume in one second (FEV1) 80 (30) versus 88 (17)% predicted) despite the fact that the men were younger (mean (SD) age 45 (18) versus 51 (17) years), and poorer in those aged 50 or older than in those aged under 50 (mean (SD) FEV1 70 (30) versus 98 (16)% predicted). Self-reported occupational exposure to gas, fumes, or dust occurred more frequently in men than in women. In those aged 50 or older lung function was lower in individuals exposed to airway irritants than those who were not exposed (mean (SD) FEV1 63 (29) versus 76 (31)% predicted). Male sex, increasing age, and previous symptoms of wheezing were independent risk factors for lung function impairment, and male sex, wheeziness, and occupational exposure to airway irritants were independent risk factors in the subjects aged 50 years or more.
CONCLUSIONS: In non-smoking PiZZ individuals lung function declines with increasing age, especially after 50. Men are at greater risk of lung function deterioration than women. Asthmatic symptoms and occupational exposure to airway irritants appear to constitute additional risk factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093340      PMCID: PMC1758519          DOI: 10.1136/thx.52.3.244

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age.

Authors:  E BERGLUND; G BIRATH; J BJURE; G GRIMBY; I KJELLMER; L SANDQVIST; B SODERHOLM
Journal:  Acta Med Scand       Date:  1963-02

2.  Pulmonary function in Pi M and MZ grainworkers.

Authors:  S L Horne; R K Tennent; D W Cockcroft; D J Cotton; J A Dosman
Journal:  Chest       Date:  1986-06       Impact factor: 9.410

3.  Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ.

Authors:  M C Wu; S Eriksson
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

4.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  alpha1-Antitrypsin deficiency in nonsmokers.

Authors:  L F Black; F Kueppers
Journal:  Am Rev Respir Dis       Date:  1978-03

6.  Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

Authors:  C Larsson
Journal:  Acta Med Scand       Date:  1978

7.  A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.

Authors:  E K Silverman; M A Province; D C Rao; J A Pierce; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1990-11

8.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

Authors:  E K Silverman; J A Pierce; M A Province; D C Rao; E J Campbell
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

9.  Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

Authors:  M L Brantly; L D Paul; B H Miller; R T Falk; M Wu; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-08

10.  Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association.

Authors:  M J Tobin; P J Cook; D C Hutchison
Journal:  Br J Dis Chest       Date:  1983-01
View more
  29 in total

Review 1.  Alpha-1-antitrypsin deficiency: what next?

Authors:  R A Stockley
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease.

Authors:  Sarah K Brode; Simon C Ling; Kenneth R Chapman
Journal:  CMAJ       Date:  2012-07-03       Impact factor: 8.262

3.  Survival in severe alpha-1-antitrypsin deficiency (PiZZ).

Authors:  Hanan A Tanash; Peter M Nilsson; Jan-Ake Nilsson; Eeva Piitulainen
Journal:  Respir Res       Date:  2010-04-26

4.  Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study.

Authors:  Karin F Kok; René H te Morsche; Martijn G H van Oijen; Joost P H Drenth
Journal:  BMC Gastroenterol       Date:  2010-02-20       Impact factor: 3.067

Review 5.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 6.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

7.  Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).

Authors:  E Piitulainen; T Sveger
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

8.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

9.  Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency.

Authors:  Annyce S Mayer; James K Stoller; Sverre Vedal; A James Ruttenber; Matt Strand; Robert A Sandhaus; Lee S Newman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.

Authors:  Adriano R Tonelli; Farshid Rouhani; Ning Li; Pam Schreck; Mark L Brantly
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.